Magnetic resonance imaging may help physicians determine which patients with depression would have better success with medication and which with psychotherapy.
Brain activity detected by functional MR imaging may help determine whether psychotherapy or antidepressant medication is more likely to help individual patients recover from depression, according to a study published in the American Journal of Psychiatry. Researchers from Emory University in Atlanta, Ga., performed a study to determine if a neuroimaging biomarker identified through MR imaging may aid in the selection of first-line treatment choice between cognitive-behavioral therapy (CBT) or an antidepressant medication for treatment-naive adults with major depressive disorder. A total of 122 patients who were part of the Prediction of Remission to Individual and Combined Treatments (PReDICT) study underwent resting state functional MRI of the brain before starting randomized treatment to either 12 weeks of CBT or antidepressant medication. The depression rating was obtained with the Hamilton Depression Rating Scale (HAM-D). "All depressions are not equal and, like different types of cancer, different types of depression will require specific treatments. Using these scans, we may be able to match a patient to the treatment that is most likely to help them, while avoiding treatments unlikely to provide benefit," lead author Helen Mayberg, MD, said in a release. Mayberg is a psychiatry, neurology, and radiology professor and the Dorothy C. Fuqua Chair in Psychiatric Imaging and Therapeutics at Emory University School of Medicine. The results showed 58 of the 122 participants achieved remission with a HAM-D score 7 or lower at weeks 10 and 12. Twenty-four had treatment failure, with a less than 30 percent decrease from baseline in HAM-D score. “The resting-state functional connectivity of the following three regions with the [subcallosal cingulate cortex (SCC)] was differentially associated with outcomes of remission and treatment failure to CBT and antidepressant medication and survived application of the subsample permutation tests: the left anterior ventrolateral prefrontal cortex/insula, the dorsal midbrain, and the left ventromedial prefrontal cortex,” the authors wrote. Using the summed SCC functional connectivity scores for these three regions, overall classification rates of 72 percent to 78 percent for remission and 75 percent to 89 for treatment failure was demonstrated. Positive summed functional connectivity was associated with remission with CBT and treatment failure with medication, whereas negative summed functional connectivity scores were associated with remission to medication and treatment failure with CBT. The authors concluded that functional imaging could identify probability of remission or treatment failure with first-line treatment options for major depression, and this should be explored in future research through prospective testing and as a component of multivariate treatment prediction models.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 2nd 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 2nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.